SynthesisJournal of ovarian research2021

The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials.

Xin-Ru Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.